SAN DIEGO – Past research has shown that patients with HIV infection vaccinated early in the flu season are generally more likely to contract influenza or influenza-like illness (ILI), compared with those receiving late vaccination. The reason likely is that… Read More
IOWA CITY, IA – Co-infection with Staphyloccocus aureus and influenza more than quadruples the risk of death compared to those without influenza, according to a new study. The article published recently in the national Centers for Disease Control and Prevention’s… Read More
ANN ARBOR, MI—Multiple national recommendations encourage all healthcare workers to get the influenza vaccination, thereby reducing the chance they will pass the virus on to their patients. Despite a patient population of older and sicker patients more likely to develop… Read More
While influenza vaccine is the first line of defense against an infectious disease that can dramatically affect troop readiness, it is far from 100% effective.
In February, five U.S. representatives from California blasted the VA in a letter to Secretary Robert McDonald, alleging the Palo Alto Medical Center failed to follow public health protocol regarding potential tuberculosis (TB) exposure.
Drawing on deep experience with flaviviruses that started with its namesake’s research on yellow fever in the 1800s, the Walter Reed Army Institute of Research (WRAIR) and collaborators brought two Zika vaccine candidates through early testing in just four months this spring.
ANN ARBOR, MI — Oral pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) gained Food and Drug Administration approval in 2012, and many commentators hailed the therapy as a “once-in-a-generation” advance.
HOUSTON — After a decade of dramatically rising rates of hepatocellular carcinoma (HCC) among veterans, aggressive treatment of hepatitis C infections (HCV) appears poised to turn the tide.
Pre-infection Immunological Health Achieved in Some Cases By Annette M. Boyle SAN ANTONIO — For years, clinicians have not recommended treating human immunodeficiency virus (HIV) patients with antiretroviral therapy (ART) before they saw a significant drop in T-cell levels. Starting… Read More
VA Researchers Recommend Against the Practice in Most Cases By Brenda L. Mooney ANN ARBOR, MI — In a case where the preventive measure might be worse than the avoided outcome, hospitals at the VHA and elsewhere often routinely provide… Read More
New Research Uncovers Some Clues to Aid Prevention By Brenda L. Mooney WASHINGTON — As the VHA works to reduce the overall post-operative rate of Clostridium difficile infection (CDI), important new research has uncovered some clues to the circumstances that… Read More
For the VA, the combination of effective treatment options and much lower prevalence of HCV in younger veterans may offer a light at the end of the tunnel — and a turning point in the steady rise of HCV-associated complications such as cirrhosis and hepatocellular carcinoma (HCC) in only a few years.
Subhead: Post-operative Mortality Rates Low Among ART Users By Annette M. Boyle WEST HAVEN, CT — Historically, high post-operative mortality rates among HIV-infected patients caused many physicians and patients to defer or avoid surgery all together. For today’s veterans with… Read More
By Brenda L. Mooney SALT LAKE CITY — A study conducted in the VA health system uncovered a disturbing truth about overuse of antibiotics: A big contributor to the problem is that some clinicians prescribe the drugs to nearly every… Read More
The VA’s methicillin-resistant Staphylococcus aureus (MRSA) prevention initiative reduced healthcare-associated MRSA infections 69% in VA acute care facilities and 81% in spinal cord injury units in five years. The VA hopes to see similar success in preventing infections with Clostridium difficile (CDI) and carbapenem-resistant Enterobacteriaceae (CRE) — and the MRSA bundle itself may help them do that.
Lower immunization rates have increased the number of U.S. outbreaks of vaccine-preventable diseases, even of those considered eradicated in this country, such as measles.
Research Contradicts Other Recent Findings By Brenda L. Mooney PHILADELPHIA — As the latest influenza season finally abates, a new VA study raises questions about how effective the high-dose vaccine really is for the 65 or older cohort. Beginning at… Read More
Amid all the outcry over the high cost of new hepatitis C therapies, including congressional hearings, a simple fact has been overlooked: The VA expects to save money in the long run because of the drugs’ high cure rates. By… Read More
By Brenda L. Mooney BOSTON – Rates of serologic testing for hepatitis B (HBV) at the VA fail to meet levels recommended by the American Association for the Study of Liver Diseases (AASLD) practice guideline, according to new research. Researchers… Read More
Higher Pneumonia Vaccine Rates Urged By Brenda L. Mooney PROVIDENCE, RI – With influenza season each year comes an even greater challenge for VA hospitals — a spate of pneumonia cases in older veterans. Recent research suggests the problem will… Read More
Free Shots Available at Walgreen’s Locations By Annette M. Boyle SAN FRANCISCO – The VA typically has influenza vaccination rates well above the national average but is trying some innovative measures to do even better. As part of the effort to increase immunizations,… Read More